The commonly used and much maligned diabetes drug, Avandia, just took another spill down the stairs. A
new mouse study shows that the drug weakens bones and is likely to cause osteoporosis in the millions of users in the United States. The drug was shown to get directly in the way of healthy bone function, causing accelerated bone loss and slowed bone growth.
Read More: Avandia,
bone function,
GlaxoSmithKline,
heart disease,
osteoporosis